Skip to main content
Retour
Watch Compare

LIFECORE BIOMEDICAL, INC. \DE\

Qualité des données : 83%
LFCR
Nasdaq Manufacturing Chemicals
4,72 €
▲ 0,48 € (11,32%)
Cap. Boursière: 176,89 M
Prix
4,72 €
Cap. Boursière
176,89 M
Fourchette du Jour
4,12 € — 4,72 €
Fourchette 52 Semaines
3,63 € — 8,98 €
Volume
994 581
Ouverture 4,22 €
Moyenne 50J / 200J
6,44 €
26,65% below
Moyenne 50J / 200J
7,26 €
35,03% below

Quick Summary

Points Clés

Earnings declined -249,51% over the past year
Generating 7,69 M in free cash flow
ROIC of 2,99% — low return on invested capital
Interest coverage of 0,35× — tight debt servicing

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)-249,51%
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROIC2,99%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio2,80
Interest Coverage0,35

Valorisation

PE (TTM)
-15,09
En dessous de la moyenne du secteur (-1,47)
P/B RatioN/A
EV/EBITDA18,61
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -15,1 -1,5
P/B — 1,6
ROE % — -53,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

ETFs Holding This Stock

GMNAX GMNAX
0,20% weight
GGMMX GGMMX
0,20% weight
GAMNX GAMNX
0,20% weight
GMNCX GMNCX
0,20% weight
EES logo EES WisdomTree U.S. SmallCap Fund
0,03% weight
TMFX TMFX
0,01% weight
AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0,00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) -249,51% Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -11,72 M
ROE N/A ROA -4,96%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) 7,69 M
ROIC 2,99% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 2,80
Interest Coverage 0,35 Asset Turnover N/A
Working Capital 53,97 M Tangible Book Value -28,62 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -15,09 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 18,61 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 4,35%
Market Cap 176,89 M Enterprise Value 293,99 M
Per Share
EPS (Diluted TTM) -0,30 Revenue / Share N/A
FCF / Share 0,21 OCF / Share 0,26
EPS CAGR (1Y) -268,75% EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion -65,64%
SBC-Adj. FCF -3,04 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2022 FY2023 FY2021
Revenue — — — — —
Net Income -17,96 M 12,01 M -97,43 M -99,56 M -32,67 M
EPS (Diluted) -0,54 0,32 -3,31 -3,32 -1,12
Gross Profit 23,69 M 41,85 M 50,37 M 27,99 M 81,47 M
Operating Income -733 000,0 -8,84 M -41,29 M -21,80 M -13,50 M
EBITDA — — — — —
R&D Expenses 4,97 M 8,58 M 7,84 M 8,74 M 10,22 M
SG&A Expenses 19,46 M 40,46 M 46,13 M 38,97 M 65,36 M
D&A 8,03 M 8,86 M 17,88 M 13,29 M 19,87 M
Interest Expense 15,85 M — 17,36 M 17,65 M —
Income Tax 337 000,0 183 000,0 -5,84 M 308 000,0 -7,80 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2022 FY2023 FY2021
Total Assets 232,18 M 253,96 M 295,16 M 253,55 M 502,92 M
Total Liabilities 198,12 M 200,06 M 187,22 M 218,46 M 300,14 M
Shareholders' Equity -14,20 M 11,32 M 107,95 M -4,23 M 202,78 M
Total Debt 142,24 M 101,59 M 98,18 M 84,84 M 164,90 M
Cash & Equivalents 17,47 M 8,46 M 1,64 M 19,09 M 1,30 M
Current Assets 82,29 M 81,03 M 123,71 M 93,88 M 148,32 M
Current Liabilities 23,57 M 38,87 M 79,23 M 39,29 M 101,89 M